Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients

Andrea Sacconi; Paola Muti; Claudio Pulito; Giulia Urbani; Matteo Allegretti; Raul Pellini; Nikolay Mehterov; Uri Ben-David; Sabrina Strano; Paolo Bossi; Giovanni Blandino

Детайли

Източник: Molecular Cancer; Molecular Cancer

Системен №: 16718

Действия

APA Chicago / Turabian (16th edition) Harvard MLA (7th edition)

Sacconi, A., Muti, P., Pulito, C., Urbani, G., Allegretti, M., Pellini, R., Mehterov, N., Ben-David, U., Strano, S., Bossi, P., Blandino, G. Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients, , .

Sacconi, A., Muti, P., Pulito, C., Urbani, G., Allegretti, M., Pellini, R., Mehterov, N., Ben-David, U., Strano, S., Bossi, P., Blandino, G. . Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients. : , .

Sacconi, A., Muti, P., Pulito, C., Urbani, G., Allegretti, M., Pellini, R., Mehterov, N., Ben-David, U., Strano, S., Bossi, P., Blandino, G. () Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients, :

Sacconi, A., Muti, P., Pulito, C., Urbani, G., Allegretti, M., Pellini, R., Mehterov, N., Ben-David, U., Strano, S., Bossi, P., & Blandino, G. (). Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients. Molecular Cancer; Molecular Cancer.

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients

Детайли

Допълнителна информация

Действия